NLM Logo

PCSK9 Inhibitors MeSH Descriptor Data 2022


MeSH Heading
PCSK9 Inhibitors
Tree Number(s)
D27.505.519.186.071.202.685
D27.505.519.389.745.800.506
D27.505.954.557.500.202.685
Unique ID
D000091362
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000091362
Scope Note
Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.
Entry Term(s)
PCSK9 Inhibitors Cardiovascular
PCSK9 Inhibitors, Cardiovascular
Registry Number
0
Previous Indexing
Anticholesteremic Agents (2018-2021)
Public MeSH Note
2022
History Note
2022
Date Established
2022/01/01
Date of Entry
2021/07/09
Revision Date
2021/07/08
PCSK9 Inhibitors Preferred
PCSK9 Inhibitors, Cardiovascular Narrower
page delivered in 0.165s